Statistics
Publications
182
Citations
24.7K
H-Index
52
Active since
2002
Jens Bedke is an author at University of Tübingen specializing in medicine, oncology, and renal cell carcinoma.
Publications per year
2002–2025
182
182
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +9
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
1–5 of 182